Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$0.94 +0.01 (+0.76%)
At close: Oct 1, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Liabilities and Shareholders Equity (2010 - 2026)

Updated

Creative Medical Technology Holdings' Liabilities and Shareholders Equity came in at $9.38 million for Q2 2026, up 32.0% from $7.11 million a year earlier and up 45.6% from the prior quarter.

Analysis

Creative Medical Technology Holdings (CELZ) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Creative Medical Technology Holdings' Liabilities and Shareholders Equity was $7.81 million, up 17.1% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of 61.2% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $6.67 million in FY2024 (-37.8%), $10.72 million in FY2023 (-44.2%), $19.19 million in FY2022 (+70.3%) and $11.27 million in FY2021.
  • The Q2 2026 figure represents the highest quarterly Liabilities and Shareholders Equity since Q1 2024.
  • Year-over-year, Liabilities and Shareholders Equity increased in two of the last eight quarters, with an average decline of 12.0%.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q3 2021 (growth of 636.5%), and the weakest in Q3 2024 (a decline of 45.0%).
  • Business Quant data shows CELZ's Liabilities and Shareholders Equity at $6.44 million (Q1 2026), $7.81 million (Q4 2025) and $5.85 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Creative Medical Technology Holdings 1.24 Mn 1.26 Mn - 9.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.38 Mn
Mar 31, 2026 6.44 Mn
Dec 31, 2025 7.81 Mn
Sep 30, 2025 5.85 Mn
Jun 30, 2025 7.11 Mn
Mar 31, 2025 8.35 Mn
Dec 31, 2024 6.67 Mn
Sep 30, 2024 6.89 Mn
Jun 30, 2024 7.99 Mn
Mar 31, 2024 9.62 Mn
Dec 31, 2023 10.72 Mn
Sep 30, 2023 12.51 Mn
Jun 30, 2023 14.13 Mn
Mar 31, 2023 15.23 Mn
Dec 31, 2022 19.19 Mn
Sep 30, 2022 22.47 Mn
Jun 30, 2022 23.43 Mn
Mar 31, 2022 9.73 Mn
Dec 31, 2021 11.27 Mn
Sep 30, 2021 3.13 Mn
API Access

Creative Medical Technology Holdings Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CELZ&period=max&api_key=YOUR_API_KEY